These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Creatine Supply Attenuates Ischemia-Reperfusion Injury in Lung Transplantation in Rats. Almeida FM; Battochio AS; Napoli JP; Alves KA; Balbin GS; Oliveira-Junior M; Moriya HT; Pego-Fernandes PM; Vieira RP; Pazetti R Nutrients; 2020 Sep; 12(9):. PubMed ID: 32927837 [TBL] [Abstract][Full Text] [Related]
49. Muse Cells and Ischemia-Reperfusion Lung Injury. Yabuki H; Watanabe T; Oishi H; Katahira M; Kanehira M; Okada Y Adv Exp Med Biol; 2018; 1103():293-303. PubMed ID: 30484236 [TBL] [Abstract][Full Text] [Related]
50. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway. Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595 [TBL] [Abstract][Full Text] [Related]
51. Liquid Ventilation Reconditions Isolated Rat Lungs Following Ischemia-Reperfusion Injury. Becerra D; Linge H; Jeffs S; Roberts S; O J; Ott HC Tissue Eng Part A; 2022 Nov; 28(21-22):918-928. PubMed ID: 35946070 [TBL] [Abstract][Full Text] [Related]
54. The effects of ischaemic conditioning on lung ischaemia-reperfusion injury. Vlastos D; Zeinah M; Ninkovic-Hall G; Vlachos S; Salem A; Asonitis A; Chavan H; Kalampalikis L; Al Shammari A; Alvarez Gallesio JM; Pons A; Andreadou I; Ikonomidis I Respir Res; 2022 Dec; 23(1):351. PubMed ID: 36527070 [TBL] [Abstract][Full Text] [Related]
55. Protective effects of hydrogen inhalation during the warm ischemia phase against lung ischemia-reperfusion injury in rat donors after cardiac death. Zhang J; Zhou H; Liu J; Meng C; Deng L; Li W Microvasc Res; 2019 Sep; 125():103885. PubMed ID: 31175855 [TBL] [Abstract][Full Text] [Related]
56. The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury. Roberts V; Lu B; Rajakumar S; Cowan PJ; Dwyer KM Purinergic Signal; 2013 Jun; 9(2):135-43. PubMed ID: 23188420 [TBL] [Abstract][Full Text] [Related]
57. The Role of Purinergic Signaling in Heart Transplantation. Jiang Y; Lin J; Zheng H; Zhu P Front Immunol; 2022; 13():826943. PubMed ID: 35529844 [TBL] [Abstract][Full Text] [Related]
58. Transcriptome analysis of novel macrophage M1-related biomarkers and potential therapeutic agents in ischemia-reperfusion injury after lung transplantation based on the WGCNA and CIBERSORT algorithms. Zhang Z; Gao J; Yu J; Zhang N; Fu Y; Jiang X; Wang X; Song J; Wen Z Transpl Immunol; 2023 Aug; 79():101860. PubMed ID: 37230395 [TBL] [Abstract][Full Text] [Related]
59. Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant. Cheng Q; Patel K; Lei B; Rucker L; Allen DP; Zhu P; Vasu C; Martins PN; Goddard M; Nadig SN; Atkinson C Am J Transplant; 2018 Oct; 18(10):2417-2428. PubMed ID: 29504277 [TBL] [Abstract][Full Text] [Related]
60. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism. Beldi G; Enjyoji K; Wu Y; Miller L; Banz Y; Sun X; Robson SC Front Biosci; 2008 Jan; 13():2588-603. PubMed ID: 17981736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]